Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
A project coordinated by the BBRC receives funding from La Marató 2022 to investigate the relationship between cardiovascular diseases and Alzheimer’s
The "Interaction between subclinical atherosclerosis and Alzheimer's disease in middle age" project, led by the Barcelonaβeta Brain Research Center, is one of the 37 beneficiaries of the previous edition of La Marató.
The SpeechDx study will generate a voice database for the exploration of speech-based biomarkers to aid in the early detection of Alzheimer’s disease
The project, supported by the Alzheimer's Drug Discovery Foundation’s Diagnostic Accelerator and with the participation of the BBRC, will collect speech, clinical and biomarker data from more than 2600 participants.
The BBRC participates in the CTAD 2023 conference
The Neuroimaging Research Group of the center has presented a talk and two posters at the 16th edition of the congress dedicated to Alzheimer's clinical trials.
The Pasqual Maragall Foundation announces the winning projects of the Alzheimer's research grants
The Pasqual Maragall Researchers Program (PMRP) will distribute a total of 1.5 million euros between the three selected projects.
Reactive astrogliosis contributes to the formation of Alzheimer’s toxic proteins and damage of brain cells in very early stages of the disease
Postdoctoral researcher Wiesje Pelkmans explains the main results of the study.
On World Alzheimer's Day we highlight the figures to forget
This September 21, we call for more research and visibility to change the social consideration of the disease through the action "4lzh31m3r: the numbers to forget"
Early action to control cardiovascular risk factors preserves brain metabolism
A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over five years.
The BBRC participates in a study to facilitate early diagnosis of Alzheimer's with a blood test
The research center of the Pasqual Maragall Foundation has made the first visit of the EAPP study in July 2023.
Presented at AAIC the results of a new drug that would slow cognitive decline
According to the data presented, and simultaneously published in JAMA, the treatment with donanemab will significantly reduce the levels of amyloid plaque.
